
Wolfgang Gleiber
Frankfurt Am Main, HE, Germany
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 14 publications
Viral Pathogen-Specific Severe Acute Respiratory Infections in Hospitalised Adults in Europe: Epidemiological Findings from the id.DRIVE Study 2024-2025.
Journal: Infectious diseases and therapy
Published: April 08, 2026
Randomised, phase 1/2a trial of ION-827359, an antisense oligonucleotide inhibitor of ENaC.
Journal: ERJ open research
Published: December 15, 2023
Corrigendum to "Biomarker testing in non-small cell lung cancer in routine care: Analysis of the first 3,717 patients in the German prospective, observational, nation-wide CRISP registry (AIO-TRK-0315)" [Lung Cancer 152 (2021) 174-184].
Journal: Lung cancer (Amsterdam, Netherlands)
Published: May 29, 2021
Real-World Efficacy of Nintedanib Plus Docetaxel After Progression on Immune Checkpoint Inhibitors: Results From the Ongoing, Non-interventional VARGADO Study.
Journal: Clinical oncology (Royal College of Radiologists (Great Britain))
Published: May 13, 2021
Biomarker testing in non-small cell lung cancer in routine care: Analysis of the first 3,717 patients in the German prospective, observational, nation-wide CRISP Registry (AIO-TRK-0315).
Journal: Lung cancer (Amsterdam, Netherlands)
Published: August 07, 2020
Alpha-1 Antitrypsin Deficiency (AATD) - D-A-CH-Expert Statement
Journal: Pneumologie (Stuttgart, Germany)
Published: June 04, 2020
Association of Disease Progression With Health-Related Quality of Life Among Adults With Breast, Lung, Pancreatic, and Colorectal Cancer.
Journal: JAMA network open
Published: March 11, 2020
Nintedanib plus docetaxel after progression on immune checkpoint inhibitor therapy: insights from VARGADO, a prospective study in patients with lung adenocarcinoma.
Journal: Future oncology (London, England)
Published: July 09, 2019
GLPG2737 in lumacaftor/ivacaftor-treated CF subjects homozygous for the F508del mutation: A randomized phase 2A trial (PELICAN).
Journal: Journal of cystic fibrosis : official journal of the European Cystic Fibrosis Society
Published: May 28, 2019
Sino nasal inhalation of isotonic versus hypertonic saline (6.0%) in CF patients with chronic rhinosinusitis - Results of a multicenter, prospective, randomized, double-blind, controlled trial.
Journal: Journal of cystic fibrosis : official journal of the European Cystic Fibrosis Society
Published: January 19, 2016
Last Updated: 09/26/2026